Ordenar

Buscar

01/10/2024 Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Augustin, M, Gottlieb, AB, Lebwohl, M, Pinter, A, Warren, RB, Puig, L, Warham, R, Lambert, J, Wiegratz, S, Szilagyi, B, Blauvelt, A. Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(10)DOI:10.1007/s13555-024-01261-6. PMID:39285121. IF:4.200(Q1/1D).
01/10/2024 Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial
Gomez-Lara, J, Lopez-Palop, R, Rumiz, E, Jurado-Roman, A, Gomez-Menchero, A, Valencia, J, Fernandez, E, Ramirez, LRG, Brugaletta, S, Millan, R, Cortes, C, Tejedor, P, Gutierrez-Barrios, A, Flores, X, Cid-alvarez, AB, Garcia-Blas, S, Garcia-Camarero, T, Vicente, JAL, Vaquerizo, B, Soriano, JGC, Caballero, J, Piris, RMC, Sanchez-Elvira, G, Oyarzabal, L, Pernigotti, A, Tramullas, A, Antuna, P, Rodriguez-Leor, O, Ojeda, S, Rossello, X, Gomez-Hospital, JA, Bermejo, J, Garcia-Garcia, HM, Prado, APD, Gutierrez-Ibanes, E. Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial. REC, interventional cardiology. 2024; 6(4)DOI:10.24875/RECIC.M24000468. PMID:. IF:(Q/D).
01/10/2024 PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.
Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.. Jacc-Basic To Translational Science. 2024; 9(10)DOI:10.1016/j.jacbts.2024.06.008. PMID:39534644. IF:(Q/D).
01/10/2024 Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes
López-Yerena, A, Muñoz-García, N, Villaplana, VD, Padro, T, Badimon, L. Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes. Nutrients. 2024; 16(20)DOI:10.3390/nu16203541. PMID:39458535. IF:5.000(Q1/2D).
30/09/2024 Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain
Puig, T, Leache, L, González-Senac, NM, Carreras, E, Gutiérrez-Valencia, M, Losa, L, Revuelta-Herrero, JL, Marrero-Alvarez, P, de Miguel, M, Arredondo, AA, Aranguren, A, Vilariño, A, Ruiz, VE, Fernández, I, Bilbao, J, González-Guerrero, C, del Pino, B, Garin, N. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain. BMC Geriatrics. 2024; 24(1)DOI:10.1186/s12877-024-05308-3. PMID:39350081. IF:3.800(Q2/4D).
30/09/2024 Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024)
Güven, S, Tokas, T, Tozsin, A, Haid, B, Lendvay, TS, Silay, S, Mohan, VC, Cansino, JR, Saulat, S, Straub, M, Tur, AB, Akguel, B, Samotyjek, J, Lusuardi, L, Ferretti, S, Cavdar, OF, Ortner, G, Sultan, S, Choong, S, Micali, S, Saltirov, I, Sezer, A, Netsch, C, de Lorenzis, E, Cakir, OO, Zeng, G, Gozen, AS, Bianchi, G, Jurkiewicz, B, Knoll, T, Rassweiler, J, Ahmed, K, Sarica, K. Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024). WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05282-w. PMID:39348069. IF:2.900(Q2/3D).
28/09/2024 Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection
Padilla-Pozo, A, Bartumeus, F, Montalvo, T, Sanpera-Calbet, I, Valsecchi, A, Palmer, JRB. Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-73416-6. PMID:39341898. IF:3.900(Q1/2D).
27/09/2024 Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer
Liu, K, Nicoletti, R, Zhao, HD, Chen, X, Wu, HW, Leung, CH, D'Andrea, D, Laukhtina, E, Soria, F, Gallioli, A, Wroclawski, ML, Castellani, D, Gauhar, V, Rivas, JG, Enikeev, D, Gontero, P, Shariat, SF, Chiu, PKF, Ng, CF, Teoh, JYC. Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05218-4. PMID:39331198. IF:2.900(Q2/3D).